Platelets and Megakaryocytes » Platelet Function and Interactions

Abstract Number: OC 49.3

A microfluidic model to study the initiation of venous thrombosis

L. Mereweather¹, J. van Batenburg-Sherwood¹, J. Ahnström¹, I. Salles-Crawley², J. Crawley¹

Abstract Number: PB0886

Alcohol intake including wine drinking is associated with decreased platelet reactivity in a large population sample

R. Pashek¹, B. Nkambule², M. Chan³, F. Thibord⁴, A. Lachapelle³, J. Cunha⁵, M. Chen³, A. Johnson³

Abstract Number: PB0888

Anaphylactic Shock To A Hematological Disorder Patient During Transfusion Of Platelet Aphaeresis Unit Stored In Platelet Additive Solution: A Rare Case Report

B. poluru mranikrinda

Abstract Number: OC 33.5

Anti-PF4 IgG levels in patients with VITT remain high at 7 months following vaccination and can still activate platelets

S. Montague¹, C. Smith², C. Lodwick³, C. Stoneley⁴, M. Roberts⁴, G. Lowe⁵, W. Lester⁴, S. Watson¹, P. Nicolson⁶

Abstract Number: PB0874

Assessing Circulation Persistence of Human Platelet Products in a NOD-SCID Mouse Model

B. Kuhn¹, K. Moskowitz²

Abstract Number: PB0881

Calcium-and integrin-binding protein 2 negatively regulates in vivo thrombosis and platelet functions by attenuating S1P production

M. Naik, K. Golla, N. Shaik, P. Patel, U. Naik

Abstract Number: OC 10.1

CD36-dependent metabolic rewiring and mitochondrial dysfunction in platelets in response to hyperlipidaemia.

L. Cheah, M. Hindle, K. Naseem

Abstract Number: PB0895

Changes in immature platelet fraction after major trauma: a prospective cohort study

A. Rossetto¹, P. Armstrong², L. Green³, K. Brohi⁴, T. Warner², P. Vulliamy⁵

Abstract Number: PB0848

Characterization of the uric acid transporter URAT1 (SLC22A12) in platelets and megakaryocytes

I. Boukhatem¹, J. Bélanger², O. Ghafoud², S. Fleury³, M. Welman³, M. Lordkipanidzé³

Abstract Number: PB0856

Chronic inflammation of the liver and bile ducts contributes to platelet hypoactivity and platelet-leukocyte aggregate formation in Mdr2-/- mice

H. Englert¹, J. Gerwers¹, N. Wolska¹, J. Krause¹, D. Schwinge¹, C. Schramm², T. Renné³

Abstract Number: VPB0902

Deletion of TGF-β1 on platelets attenuates pulmonary arterial hypertension by enhancing aerobic glycolysis of pulmonary arterial smooth muscle cell

Z. Ming, Y. Zhu, X. Gong, M. Lu, X. Zeng, J. Gao, Y. Guo, L. Liu, R. Ma

Abstract Number: PB0868

Detection of hyperfunctioning platelets and novel phenotypic platelet subtypes

M. Jongen, L. Schmied, S. Meinke, R. Fiskesund, P. Höglund

Abstract Number: PB0867

Development of an endothelialized in vitro thrombosis model with a disease relevant extracellular matrix

A. Drysdale¹, A. Unsworth², S. White¹, S. Jones¹

Abstract Number: OC 09.3

Differential fate of Von Willebrand factor and Von Willebrand factor propeptide following release from platelet alpha-granules

M. Swinkels¹, T. Lemmens², P. Burgisser³, J. Slotman⁴, A. Houtsmuller⁴, J. Cosemans², F. Leebeek³, J. Voorberg⁵, A. Jansen⁶, R. Bierings⁷

Abstract Number: PB0877

Discriminating platelet subpopulations on the expression level of HLA-I highlights the high reactivity of young versus old platelets

C. Angénieux¹, A. Couvidou¹, N. Brouard¹, A. Eckly², P. Mangin¹, B. Maître¹

Abstract Number: PB0858

Effect of Agonist Stimulation and Antiplatelet Drugs on Platelet Contractility

D. Hiebner¹, M. Kenny¹, S. Lickert², I. Schoen¹

Abstract Number: PO0049

Effect of platelet-rich plasma in combination with autologous adipose- derived mesenchymal stem cell in treatment of calcaneal enthesophytes.

f. marhoume¹, Y. Naasse¹, B. MA², E. Rajae¹, B. anas³

Abstract Number: VPB0901

Effects of platelets activated by different agonists on fibrin formation and thrombin generation.

I. Muravlev¹, A. Dobrovolsky², O. Antonova¹, S. Khaspekova¹, A. Mazurov¹

Abstract Number: PB0889

Endogenous nitroxyl (HNO) production in a normal biological system and its role in platelet function.

R. Pozner¹, Y. Doctorovich¹, M. Maccaferro¹, S. Suarez², M. Marti³, F. Doctorovich², P. Ivani¹, M. Schattner¹

Abstract Number: PB0854

Evaluation of the hemostatic ability of the new device Total Thrombus Formation Analysis System’ (T-TAS) for thrombocytopenic patients. In vitro effect of Thrombosomes®

S. Samanbar¹, A. Moreno-Castaño², J. Piñeyroa³, M. Pino⁴, S. Torramade-Moix⁵, J. Martinez-Sanchez⁶, K. Moskowitz⁷, G. Escolar⁵, M. Diaz-Ricart⁸